Evidence map›Paper›PMID 35535330›Full record

ArticleBiochemistry and biophysics reports2022

Taka Asari, Hidezumi Kikuchi, Shogo Kawaguchi, Hirotake Sakuraba, Shukuko Yoshida, Yui Akemoto, Takato Maeda, Ota Shinji, Yasuhisa Murai, Naoki Higuchi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Experimental and therapeutic medicine · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Taka AsariDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Hidezumi KikuchiDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Shogo KawaguchiDepartment of Vascular Biology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Hirotake SakurabaDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Shukuko YoshidaShibata Irika Co. Ltd., 3-7-1-Takada, Hirosaki, Aomori, 036-8084, Japan.
Yui AkemotoDepartment of Anatomic Pathology, Hirosaki University Hospital, 53-Honcho, Hirosaki, Aomori, 036-8563, Japan.
Takato MaedaDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Ota ShinjiDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Yasuhisa MuraiDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Naoki HiguchiDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Kentaro HoshiDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Yukari FukutokuDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Hiroto HiragaDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Kenroh SasakiDivision of Pharmacognosy, Tohoku Medical and Pharmaceutical University, 4-4-1- Komatsushima, Aobaku, Sendai, Miyagi, 981-8558, Japan.
Shinsaku FukudaDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
Hirosaki University · JPHirosaki University Hospital · JPTohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indigo naturalis, a herbal medicine purified from indigo-containing plants, such as

Indexed as

AhR, aryl hydrocarbon receptorAryl hydrocarbon receptor pathwayCD, Crohn's diseaseDSS, sodium dextran sulfateEDTA, ethylenediaminetetraacetic acidHBSS, Hank's balanced salt solutionH & E, hematoxylin and eosinHPLC, high performance liquid chromatographyIBD, inflammatory bowel diseaseIECs, intestinal epithelial cellsIFN, interferonIL, interleukinIndigo naturalisInterleukin-10LP, lamina propriaPAH, pulmonary arterial hypertensionPolygonum tinctoriumqRT-PCR, quantitative real-time reverse transcription polymerase chain reactionSEM, standard error of the meanTGF, transforming growth factorTNF, tumor necrosis factorUC, ulcerative colitisulcerative Colitis

Identifiers

PMID35535330
PMCPMC9077533
OpenAlexW4225409634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.